Patent · US Active

Monoclonal antibodies against JC virus

US12410238B2 · kind B2 · utility

0Cited by
1References
28Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 19, 2020
Grant dateSep 9, 2025
Priority date
Expiry dateSep 13, 2042

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Provided herein are monoclonal antibodies and antigen-binding fragments thereof that bind to the John Cunningham virus. Also provided are pharmaceutical compositions comprising the monoclonal antibodies and antigen-binding fragments thereof, as well as methods of using such monoclonal antibodies and antigen-binding fragments thereof, including methods for the treatment and/or prevention of JCV infections and/or progressive multifocal leukoencephalopathy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.